Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 38.5a

23 Nov 2015 12:04

RNS Number : 6272G
GoldmanSachs International
23 November 2015
 

Ap24

 

FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

(GS) GOLDMAN SACHS INTERNATIONAL

Company dealt in

PFIZER INC

Class of relevant security to which the dealings being disclosed relate (Note 1)

USD Ordinary

Date of dealing

20 November 2015

 

2. DEALINGS (Note 2)

 

(a) Purchases and sales

 

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid

(Note 3)

175,607

32.4500 USD

32.1800 USD

 

Total number of securities disposed

Highest price received (Note 3)

Lowest price received

(Note 3)

175,607

32.3204 USD

32.1800 USD

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit

(Note 3)

 

Ap25

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

Call Option / (1.00 : 100.00)

Purchasing

6 (600)

33.0000 USD

AMERICAN

18/12/2015

0.6900 USD

Call Option / (1.00 : 100.00)

Purchasing

21 (2,100)

33.0000 USD

AMERICAN

20/11/2015

0.0100 USD

Call Option / (1.00 : 100.00)

Purchasing

4 (400)

33.0000 USD

AMERICAN

18/12/2015

0.7700 USD

Put Option / (1.00 : 100.00)

Purchasing

2 (200)

32.0000 USD

AMERICAN

20/11/2015

0.0200 USD

Put Option / (1.00 : 100.00)

Purchasing

2 (200)

32.0000 USD

AMERICAN

20/11/2015

0.0200 USD

Put Option / (1.00 : 100.00)

Purchasing

1 (100)

32.0000 USD

AMERICAN

20/11/2015

0.0200 USD

 

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

Call Warrant

Purchasing

3,000

28.0000 USD

AMERICAN

16/09/2016

0.5000 EUR

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)

 

3.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securitiesunder any option referred to on this form or relating to the voting rights or future acquisitionor disposal of any relevant securities to which any derivative referred to on this form is referenced.If none, this should be stated.

 

 

 

Date of disclosure

23 November 2015

Contact name

Aadithya Rao and Yiannis Bardis

Telephone number

+44(20) 7051 9046 / +44(20) 7774 7107

Name of offeree/offeror with which connected

Pfizer Inc

Nature of connection (Note 6)

Advisor to Offeror

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEEAAFDAEASFFF
Date   Source Headline
9th May 201412:11 pmRNSForm 8.3 - AstraZeneca Plc
9th May 201412:07 pmRNSForm 8.3 - [Pfizer Inc]
9th May 201411:56 amRNSForm 8.3 - [AstraZeneca plc]
9th May 201411:55 amRNSForm 8.3 - Pfizer Inc
9th May 201411:43 amBUSForm 8.3 - Pfizer Inc
9th May 201411:37 amRNSForm 8 (DD) - [Pfizer Inc]
9th May 201411:34 amRNSForm 8.5 (EPT/RI)
9th May 201411:23 amRNSForm 8.3 - Pfizer Inc
9th May 201411:00 amRNSRule 2.10 Announcement
9th May 201410:48 amRNSForm 8.5 (EPT/RI) Pfizer INC
9th May 201410:47 amRNSForm 8.5 (EPT/RI) Pfizer INC
9th May 201410:45 amRNSForm 8.5 (EPT/RI) Pfizer INC
9th May 201410:44 amRNSForm 8.5 (EPT/RI) Pfizer INC
9th May 20149:56 amRNSRule 2.10 Announcement
9th May 20147:00 amRNSForm 8.5 (EPT/RI) - Pfizer Inc. - Amendment
9th May 20147:00 amRNSForm 8 (DD) - Pfizer Inc.
9th May 20147:00 amRNSForm 8.5 (EPT/RI) - Pfizer Inc.
9th May 20147:00 amRNSForm 8 (DD) - [Pfizer Inc] - Amendment
9th May 20147:00 amRNSForm 8.5 (EPT/RI) - Pfizer Inc.
9th May 20147:00 amRNSForm 8.5 (EPT/RI) - Pfizer Inc.
9th May 20147:00 amRNSForm 8.5 (EPT/RI) - Pfizer Inc. - Amendment
9th May 20147:00 amRNSForm 8 (DD) - [Pfizer Inc] - Amendment
8th May 20144:27 pmRNSForm 8.5 (EPT/RI)Replacement - Pfizer INC
8th May 20144:25 pmRNSForm 8.5 (EPT/RI)Replacement - Pfizer INC
8th May 20144:21 pmRNSForm 8.5 (EPT/RI)- Replacement - Pfizer INC
8th May 20144:19 pmRNSForm 8.5 (EPT/RI)Replacement - Pfizer INC
8th May 20144:19 pmRNSForm 8.5 (EPT/RI)Replacement - Pfizer INC
8th May 20144:15 pmRNSForm 8.5 (EPT/RI)Replacement - Pfizer INC
8th May 20143:51 pmBUSForm 8.3 - Pfizer Inc.
8th May 20143:34 pmRNSForm 8.3 - Pfizer Inc
8th May 20143:18 pmRNSForm 8.3 - AstraZeneca Plc
8th May 20143:10 pmBUSForm 8.3 - Pfizer Inc
8th May 20142:56 pmRNSForm 8.3 - Pfizer Inc
8th May 20142:47 pmRNSForm 8.3 - Pfizer Inc
8th May 20142:46 pmBUSForm 8.3 - Pfizer Inc - Amendment
8th May 20142:45 pmBUSForm 8.3 - Pfizer Inc
8th May 20142:28 pmRNSForm 8.3 - Pfizer Inc.
8th May 20142:25 pmRNSForm 8.3 - Pfizer Inc
8th May 20142:02 pmRNSForm 8.3 - Astrazeneca PLC
8th May 20142:01 pmRNSForm 8.3 - Pfizer Inc
8th May 20141:59 pmRNSForm 8.3 - [Pfizer Inc]
8th May 20141:07 pmRNSForm 8.3 - AstraZeneca Plc
8th May 20141:03 pmRNSForm 8.3 - Pfizer Inc
8th May 201412:56 pmBUSForm 8.3 - Pfizer Inc.
8th May 201412:51 pmRNSForm 8.5 (EPT/RI) - Pfizer Inc.
8th May 201412:37 pmRNSForm 8.5 (EPT/NON-RI)
8th May 201412:33 pmRNSForm 8.5 (EPT/RI)
8th May 201411:58 amRNSForm 8 (DD) - [Pfizer Inc]
8th May 201411:55 amRNSForm 8.3 - Pfizer Inc.
8th May 201411:53 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.